Newsletter | November 3, 2026

11.03.26 -- Inside NIH's Strategy For Standardizing Organoid Models

FEATURED EDITORIAL

Inside NIH's Strategy For Standardizing Organoid Models

Srivatsan Kidambi, Director of the NIH Standardized Organoid Modeling (SOM) Center explains why NIH's SOM Center began with four distinct organ systems. Rather than creating one universal standard, the goal was to stress-test standardization frameworks across diverse biological challenges. The discussion introduces one of the dominant themes of the webinar: context of use.

Beyond Apoptosis: Context Is The Target

Cells that evade apoptosis do not necessarily evade death; they may remain vulnerable to ferroptosis, pyroptosis, necroptosis, or another regulated cell death program.

Closing The Loop Between AI And Experimental Biology

We caught up with Rosie Rodriguez, Ph.D., president of growth at Relation, to discuss AI’s place in accelerating discovery

INDUSTRY INSIGHTS

In Vitro Dissolution Methodologies For Amorphous Solid Dispersions

With the availability of so many types of in vitro dissolution tests, how do you determine which one will be most effective in predicting in vivo performance of your BCS II or IV drug product?

Unlocking Challenging Targets With Macrocycle DNA-Encoded Libraries

Discover how macrocycle DNA-encoded libraries can uncover new opportunities for challenging targets and help researchers translate promising screening hits into starting points for drug discovery.

7 Causes Of Unresolved Density And How To Investigate Them

Missing cryo-EM density does not always indicate disorder. Learn how flexibility, conformational variation, incomplete occupancy, and more can shape what is visible in a protein structure.

LNP-Mediated Cell Transfection In Bioreactors Across Workflows

Lipid nanoparticles are redefining immune cell engineering. Delve into new data that demonstrates the performance across multiple cell types and bioreactor systems, supporting their potential workflows.

FAIR Data—What Does It Mean For The Lab Scientist?

Over 70% of scientists don't know FAIR data, but it is key to AI and reproducibility. See how structured data transforms research efficiency and unlocks long-term value across R&D.

Streamlining The Path To Phase 1 For Challenging APIs

A comprehensive approach to evaluating drug molecules for the selection of a lead solid form and formulation can significantly accelerate development timelines and limit risks in later development.

SOLUTIONS

AI-Enabled Route Scouting Service

Which Organ-Chip Design Is Right For You?

Prepare For Successful Biomarker Profiling From Cell-Free DNA